samedan logo
 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Pharma Regulation in a Post-Brexit Landscape


As European pharmaceutical companies invest in new areas of gene and cell therapy, the regulations surrounding these medicinal areas are becoming more and more complex and evolving at a rapid rate. These industry developments add to an ever-changing regulatory landscape, which has led to pharmaceutical regulatory consultancies being increasingly brought in to help these companies navigate the highly technical challenges.

 Maureen Graham, MD of pharmaceutical technical services and consulting group Diamond Pharma Services, says that as guidelines are changing all the time, it is critical that pharma companies stay up-to-date in order to progress new products as quickly and smoothly as possible. 

 “When you work in cutting-edge arenas that have hundreds of guidelines, ensuring rigorous regulatory support and pharmacovigilance when it comes to strategy, development and clinical trials, for example, is obviously extremely important,” she observes.

 “This means that pharma companies need support over the full regulatory spectrum, from regulatory services through to pharmacovigilance and compliance. We’ve recently moved to a new state-of-the-art office in order to better facilitate that kind of integration, offer a thorough, joined-up view of regulatory developments, and stay at the forefront of this sector. Such services are going to be even more valued moving forward due to events like Brexit.”

 She says that the pharmaceutical industry is at a particularly exciting stage, with the increasing prevalence of cutting-edge gene and cell therapies as well as new biologic and biotech products. “But the reality is that with this comes added regulatory complexity. For example, even established US companies can find the transition to the European frameworks to be very challenging. The Regulatory Authorities within Europe have a different focus which requires a careful and rigorous translation of development plans and regulatory interactions. There are also new schemes, such as the European Medical Agency’s PRIME Scheme, which bring great opportunities that we like to be involved in. Our vigilance in staying on top of external changes meant we were able to help a company become one of the first to be accepted onto this scheme.” 

 The impending impact of Brexit could further increase this complexity, but Dr Graham is optimistic that, while the shift will have a considerable effect, pharmaceutical regulatory consultancies with the right specialist knowledge are well-positioned to facilitate operations in the new regulatory dynamics of a post-Brexit pharma world.

 If you have experience in European regulatory affairs, that won’t become obsolete overnight. Pharma companies will still need support in European markets – that’s why we’ve invested in maintaining a strong presence in the region, with offices in the Netherlands, Spain and Central Europe. They may have to take actions such as extracting their marketing authorisations from Europe and submitting as nationals instead. If they don’t have the resource or expertise internally, then consultancies will continue to have their part to play.”

 

 


About Diamond Pharma Services (https://www.diamondpharmaservices.com)

Diamond Pharma Services is a leading technical services and consulting group, providing expert support and advice to pharmaceutical and biotechnology companies. Through analysis, interpretation and distillation of data, Diamond Pharma Services helps obtain and maintain medicinal product licenses across all stages of a product’s life cycle.

The company focuses on three core areas: regulatory, pharmacovigilance and compliance.

Diamond Pharma Services’ staff are experts in EU regulatory, pharmacovigilance, compliance and quality. The company has three offices in continental Europe and is well placed to provide continuity of service regardless of the outcome of the Brexit negotiations.

In the US Diamond Pharma Services has a collaborative network of providers to assist companies in the navigation between EU and US regulatory pathways.

For further information please contact:

olly@kisscom.co.uk or victoria@kisscom.co.uk

01223 911 123
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Zenith Technologies Wins ‘Supplier of the Year’ at Pharma Industry Awards 2018

Zenith Technologies, a world leader in delivering manufacturing software to the life sciences industry, has been named ‘Pharma Supplier of the Year’ at the prestigious 2018 Pharma Industry Awards.
More info >>


White Papers

Stripping the confusion out of PVC curtains... and a new seat range.

Teknomek Ltd

With the ever-growing trend towards modularisation of clean rooms and laboratories; Teknomek have responded with a new range of PVC strip curtains, suitable for use in environments where maintaining clean airflow is critical. This new PVC curtain range includes specialist perforated and electrostatic discharge alternatives to the standard options of clear and polar (-25oC) versions.
More info >>

Industry Events

Clinical Trial Supply Europe 2019

13-14 March 2019, Milan, Italy

Following on from our largest and most engaging meeting to date, Clinical Trial Supply Europe will be returning to Milan for its 20th year in 2019! The 19th annual edition welcomed pharmaceutical companies across Europe who got together to share knowledge and issues regarding clinical trial supplies, both with regards to operational and technological challenges. Over the two days, delegates discussed issues which affected their business in our dedicated operational and technological streams.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement